Mersacidin Total Synthesis Solid-phase Peptide Synthesis

Mersacidin, a member of the lantibiotic family, is a potent antimicrobial peptide that has garnered significant attention due to its activity against multidrug-resistant bacteria, particularly methicillin-resistant Staphylococcus aureus (MRSA). Because of that, the total synthesis of mersacidin is a complex endeavor that combines the strategies of solid-phase peptide synthesis (SPPS) and nuanced chemical modifications to introduce its characteristic thioether bridges. This article breaks down the intricacies of mersacidin's structure, the challenges and methodologies employed in its total synthesis using SPPS, and the significance of this achievement in the broader context of antibiotic research and development.

Mersacidin: Structure and Bioactivity

Mersacidin is a 20-amino acid peptide characterized by the presence of multiple unusual amino acids and intramolecular thioether bridges, which contribute to its rigid three-dimensional structure. Here's the thing — these thioether bridges are formed by the addition of cysteine thiol groups to dehydro residues, typically dehydroalanine (Dha) or dehydrobutyrine (Dhb). These modifications are crucial for the peptide's biological activity, as they constrain the conformational flexibility and enhance its binding affinity to its target.

Key Structural Features of Mersacidin:

Lantibiotic Structure: Mersacidin belongs to the class of lantibiotics, which are characterized by the presence of lanthionine (Lan) and methyllanthionine (MeLan) residues, formed by the intramolecular addition of cysteine thiols to dehydroalanine (Dha) or dehydrobutyrine (Dhb).
Thioether Bridges: These bridges create a network of covalent cross-links within the peptide, imparting rigidity and stability. Mersacidin contains multiple thioether bridges.
Unusual Amino Acids: Mersacidin contains dehydroalanine (Dha) and dehydrobutyrine (Dhb) residues, which are essential for the formation of thioether bridges.
N-Terminal Modification: The N-terminus of mersacidin is modified with a unique N-terminal blocking group, which can influence its activity and stability.

Mersacidin's mechanism of action involves binding to bacterial cell wall precursor lipid II, preventing its incorporation into the peptidoglycan layer and thus inhibiting cell wall synthesis. This mechanism differs from that of many conventional antibiotics, making mersacidin an attractive candidate for combating resistance.

Challenges in Mersacidin Total Synthesis

The total synthesis of mersacidin presents several formidable challenges:

Synthesis of Unusual Amino Acids: The incorporation of dehydroalanine (Dha) and dehydrobutyrine (Dhb) residues requires specialized synthetic strategies.
Selective Formation of Thioether Bridges: The formation of multiple thioether bridges with precise regiochemistry and stereochemistry is a significant challenge. Protecting group strategies and carefully controlled reaction conditions are essential to achieve selective cyclization.
Solid-Phase Peptide Synthesis (SPPS): While SPPS provides a reliable platform for peptide assembly, optimizing the synthesis conditions for mersacidin is crucial to minimize side reactions and ensure high yields.
Folding and Cyclization: Achieving the correct folding and cyclization of the linear peptide precursor is essential for biological activity.

Solid-Phase Peptide Synthesis (SPPS) Strategies

Solid-phase peptide synthesis (SPPS) is a cornerstone of modern peptide chemistry, enabling the efficient assembly of peptides on a solid support. The SPPS approach to mersacidin total synthesis typically involves the following steps:

Resin Selection: The choice of resin is critical for successful SPPS. Common resins include Wang resin, Rink amide resin, and chlorotrityl resin. The resin is selected based on the desired C-terminal protecting group and the compatibility with the subsequent synthetic steps.
Amino Acid Protection: Amino acids are protected with Nα-protecting groups, such as fluorenylmethyloxycarbonyl (Fmoc) or tert-butyloxycarbonyl (Boc), to prevent unwanted polymerization during chain elongation. Fmoc chemistry is widely used in SPPS due to its base lability and compatibility with a wide range of side-chain protecting groups.
Chain Elongation: The peptide chain is elongated by sequentially adding amino acid residues to the resin-bound peptide. Each coupling cycle involves:
- Deprotection: Removal of the Nα-protecting group using a base, such as piperidine for Fmoc chemistry.
- Activation: Activation of the incoming amino acid using coupling reagents, such as O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate (HBTU) or O-(6-chlorobenzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate (HCTU).
- Coupling: Addition of the activated amino acid to the resin-bound peptide.
Introduction of Dehydro Residues: The introduction of dehydroalanine (Dha) and dehydrobutyrine (Dhb) residues is a key step in mersacidin synthesis. Several methods can be used to introduce these unsaturated amino acids:
- β-Elimination: This method involves the elimination of a leaving group from a suitably protected serine or threonine derivative. As an example, treatment of a β-hydroxyamino acid with a base can generate the corresponding dehydro residue.
- Oxidation: Oxidation of alanine or α-aminobutyric acid derivatives can also generate dehydro residues.
Thioether Bridge Formation: The formation of thioether bridges is achieved by the intramolecular addition of cysteine thiol groups to the dehydro residues. This process typically requires careful control of the reaction conditions, including pH, temperature, and solvent. Protecting groups are used to see to it that only the desired thioether bridges are formed.
Deprotection and Cleavage: After the peptide chain is assembled and the thioether bridges are formed, the peptide is cleaved from the resin and the side-chain protecting groups are removed using strong acids, such as trifluoroacetic acid (TFA).
Purification: The crude peptide is purified using high-performance liquid chromatography (HPLC) to obtain the desired product.
Folding and Oxidation: The purified peptide may require further folding and oxidation steps to achieve the correct three-dimensional structure.

Detailed Synthetic Strategies for Mersacidin

Several research groups have reported successful total syntheses of mersacidin, each employing unique strategies to address the challenges outlined above. Here are some notable approaches:

Strategy 1: Linear Synthesis with Late-Stage Cyclization

This strategy involves synthesizing the linear peptide precursor on a solid support, introducing the dehydro residues, and then performing the thioether bridge formation in the late stages of the synthesis.

SPPS Assembly: The linear peptide is assembled using standard Fmoc SPPS protocols.
Introduction of Dha/Dhb: Dehydroalanine (Dha) and dehydrobutyrine (Dhb) residues are introduced by β-elimination of suitably protected serine and threonine derivatives. To give you an idea, serine residues can be converted to Dha by treatment with diethyl azodicarboxylate (DEAD) and triphenylphosphine (PPh3), followed by base-mediated elimination.
Selective Thioether Formation: Selective thioether bridge formation is achieved by using orthogonal protecting groups on the cysteine residues. Here's one way to look at it: acetamidomethyl (Acm) and tert-butyl (tBu) protecting groups can be used to differentiate the cysteine thiols. The Acm group can be selectively removed using iodine, allowing the first thioether bridge to form. Subsequent removal of the tBu group enables the formation of the second thioether bridge.
Global Deprotection and Cleavage: After the thioether bridges are formed, the peptide is cleaved from the resin and globally deprotected using TFA.
Purification and Folding: The crude peptide is purified by HPLC, and the final product is obtained after lyophilization. Folding and oxidation steps may be required to achieve the native conformation.

Strategy 2: Convergent Synthesis with Fragment Condensation

This strategy involves synthesizing smaller peptide fragments separately and then coupling them together to form the complete peptide. This approach can be advantageous for complex peptides like mersacidin, as it allows for the synthesis of individual fragments with greater ease and efficiency.

For more on this topic, read our article on who is jill halfpenny daughter or check out which word is a synonym of intermittent.

Fragment Synthesis: Peptide fragments are synthesized using Fmoc SPPS. Each fragment contains the necessary dehydro residues and cysteine residues for thioether bridge formation.
Fragment Coupling: The peptide fragments are coupled together using chemoselective ligation methods, such as native chemical ligation (NCL). NCL involves the reaction of a C-terminal thioester with an N-terminal cysteine residue to form a native peptide bond.
Thioether Formation: After fragment coupling, the thioether bridges are formed using similar methods as described in the linear synthesis strategy.
Deprotection and Cleavage: The peptide is cleaved from the resin and globally deprotected using TFA.
Purification and Folding: The crude peptide is purified by HPLC, and the final product is obtained after lyophilization. Folding and oxidation steps may be required to achieve the native conformation.

Strategy 3: Thioether Bridge Formation on Solid Support

This strategy involves forming the thioether bridges while the peptide is still attached to the solid support. This approach can improve the selectivity of the thioether bridge formation, as the resin-bound peptide is sterically constrained.

SPPS Assembly: The linear peptide is assembled using standard Fmoc SPPS protocols.
Introduction of Dha/Dhb: Dehydroalanine (Dha) and dehydrobutyrine (Dhb) residues are introduced by β-elimination of suitably protected serine and threonine derivatives.
Selective Thioether Formation: Selective thioether bridge formation is achieved by using orthogonal protecting groups on the cysteine residues. The thioether bridges are formed sequentially by selectively removing the protecting groups and allowing the thiol groups to react with the dehydro residues.
Deprotection and Cleavage: After the thioether bridges are formed, the peptide is cleaved from the resin and globally deprotected using TFA.
Purification and Folding: The crude peptide is purified by HPLC, and the final product is obtained after lyophilization. Folding and oxidation steps may be required to achieve the native conformation.

Scientific Explanation of Thioether Bridge Formation

The formation of thioether bridges in mersacidin involves the nucleophilic addition of a cysteine thiol group to a dehydroalanine (Dha) or dehydrobutyrine (Dhb) residue. This reaction is typically carried out under basic conditions to deprotonate the thiol group, making it a stronger nucleophile.

Mechanism of Thioether Formation:

Deprotonation: The cysteine thiol group is deprotonated by a base, generating a thiolate anion.
Nucleophilic Attack: The thiolate anion attacks the β-carbon of the dehydroalanine (Dha) or dehydrobutyrine (Dhb) residue, which is electrophilic due to the presence of the α,β-unsaturated carbonyl group.
Conjugate Addition: The thiolate anion undergoes a conjugate addition to the dehydro residue, forming a thioether bond.
Protonation: The resulting enolate is protonated to give the final thioether product.

The selectivity of the thioether bridge formation is crucial for the synthesis of mersacidin. Now, protecting groups are used to make sure only the desired cysteine thiols react with the dehydro residues. The reaction conditions, including pH, temperature, and solvent, are carefully optimized to minimize side reactions and maximize the yield of the desired product.

Significance of Mersacidin Total Synthesis

The total synthesis of mersacidin is a significant achievement in the field of peptide chemistry and antibiotic research. It demonstrates the power of chemical synthesis to access complex natural products and provides a platform for further investigation of mersacidin's biological activity and mechanism of action.

Key Implications:

Access to Mersacidin Analogs: Total synthesis allows for the creation of mersacidin analogs with modified structures and properties. These analogs can be used to probe the structure-activity relationship of mersacidin and to develop more potent and selective antibiotics.
Understanding Mechanism of Action: Synthetic mersacidin can be used in biochemical and biophysical studies to elucidate its mechanism of action. This knowledge can guide the development of new antibiotics that target the same pathway.
Overcoming Antibiotic Resistance: Mersacidin's unique mechanism of action, which involves binding to lipid II, makes it an attractive candidate for combating antibiotic resistance. Total synthesis can provide a reliable source of mersacidin for preclinical and clinical studies.
Advancing Synthetic Methodology: The total synthesis of mersacidin has driven the development of new synthetic methodologies for the synthesis of complex peptides and lantibiotics. These methodologies can be applied to the synthesis of other natural products and pharmaceuticals.

Future Directions

The total synthesis of mersacidin has opened up new avenues for research and development in the field of antibiotic discovery. Future research efforts will likely focus on:

Developing More Efficient Synthetic Routes: Streamlining the synthetic route to mersacidin to improve the overall yield and reduce the cost of production.
Exploring Mersacidin Analogs: Synthesizing and evaluating mersacidin analogs with improved potency, selectivity, and pharmacokinetic properties.
Investigating Mechanism of Resistance: Studying the mechanisms of resistance to mersacidin to identify strategies for overcoming resistance.
Developing Mersacidin-Based Therapeutics: Developing mersacidin-based therapeutics for the treatment of MRSA and other multidrug-resistant bacterial infections.

Conclusion

The total synthesis of mersacidin via solid-phase peptide synthesis is a remarkable feat of chemical synthesis. This achievement not only provides access to mersacidin for further biological studies but also paves the way for the development of novel antibiotics to combat the growing threat of antibiotic resistance. It showcases the layered strategies required to construct complex peptides containing unusual amino acids and thioether bridges. The future of mersacidin research holds great promise for the discovery of new and effective treatments for bacterial infections.